Onconova Therapeutics - Delisted Stock
Onconova Therapeutics is currently unavailable and cannot be used in your analysis. The information on this page reflects the last day Onconova Therapeutics was actively traded. Please check the stock traded under the symbol TRAW.
Onconova Therapeutics Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Onconova Therapeutics market risk premium is the additional return an investor will receive from holding Onconova Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Onconova Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Onconova Therapeutics' alpha and beta are two of the key measurements used to evaluate Onconova Therapeutics' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 20.84 | |||
| Semi Deviation | 0.9552 | |||
| Standard Deviation | 85.82 | |||
| Variance | 7365.24 |
Delisting Warning - ONTX
Onconova Therapeutics was delisted
| The entity Onconova Therapeutics with a symbol ONTX was delisted from NASDAQ Exchange. Please try Traws Pharma with a symbol TRAW from now on. Check all delisted instruments accross multiple markets. |
Onconova Therapeutics Corporate Management
| Mark CPA | CFO COO | Profile | |
| Victor MD | Chief Officer | Profile | |
| Mark MD | Chief Officer | Profile | |
| Adar Silverstein | Sr Devel | Profile |
Still Interested in Onconova Therapeutics?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Consideration for investing in Onconova Stock
If you are still planning to invest in Onconova Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Onconova Therapeutics' history and understand the potential risks before investing.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |